Cargando…

High Resolution Melt analysis for mutation screening in PKD1 and PKD2

BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disorder. It is characterized by focal development and progressive enlargement of renal cysts leading to end-stage renal disease. PKD1 and PKD2 have been implicated in ADPKD pathogenesis but genetic...

Descripción completa

Detalles Bibliográficos
Autores principales: Bataille, Stanislas, Berland, Yvon, Fontes, Michel, Burtey, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206831/
https://www.ncbi.nlm.nih.gov/pubmed/22008521
http://dx.doi.org/10.1186/1471-2369-12-57
_version_ 1782215490616164352
author Bataille, Stanislas
Berland, Yvon
Fontes, Michel
Burtey, Stéphane
author_facet Bataille, Stanislas
Berland, Yvon
Fontes, Michel
Burtey, Stéphane
author_sort Bataille, Stanislas
collection PubMed
description BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disorder. It is characterized by focal development and progressive enlargement of renal cysts leading to end-stage renal disease. PKD1 and PKD2 have been implicated in ADPKD pathogenesis but genetic features and the size of PKD1 make genetic diagnosis tedious. METHODS: We aim to prove that high resolution melt analysis (HRM), a recent technique in molecular biology, can facilitate molecular diagnosis of ADPKD. We screened for mutations in PKD1 and PKD2 with HRM in 37 unrelated patients with ADPKD. RESULTS: We identified 440 sequence variants in the 37 patients. One hundred and thirty eight were different. We found 28 pathogenic mutations (25 in PKD1 and 3 in PKD2 ) within 28 different patients, which is a diagnosis rate of 75% consistent with literature mean direct sequencing diagnosis rate. We describe 52 new sequence variants in PKD1 and two in PKD2. CONCLUSION: HRM analysis is a sensitive and specific method for molecular diagnosis of ADPKD. HRM analysis is also costless and time sparing. Thus, this method is efficient and might be used for mutation pre-screening in ADPKD genes.
format Online
Article
Text
id pubmed-3206831
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32068312011-11-03 High Resolution Melt analysis for mutation screening in PKD1 and PKD2 Bataille, Stanislas Berland, Yvon Fontes, Michel Burtey, Stéphane BMC Nephrol Research Article BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disorder. It is characterized by focal development and progressive enlargement of renal cysts leading to end-stage renal disease. PKD1 and PKD2 have been implicated in ADPKD pathogenesis but genetic features and the size of PKD1 make genetic diagnosis tedious. METHODS: We aim to prove that high resolution melt analysis (HRM), a recent technique in molecular biology, can facilitate molecular diagnosis of ADPKD. We screened for mutations in PKD1 and PKD2 with HRM in 37 unrelated patients with ADPKD. RESULTS: We identified 440 sequence variants in the 37 patients. One hundred and thirty eight were different. We found 28 pathogenic mutations (25 in PKD1 and 3 in PKD2 ) within 28 different patients, which is a diagnosis rate of 75% consistent with literature mean direct sequencing diagnosis rate. We describe 52 new sequence variants in PKD1 and two in PKD2. CONCLUSION: HRM analysis is a sensitive and specific method for molecular diagnosis of ADPKD. HRM analysis is also costless and time sparing. Thus, this method is efficient and might be used for mutation pre-screening in ADPKD genes. BioMed Central 2011-10-18 /pmc/articles/PMC3206831/ /pubmed/22008521 http://dx.doi.org/10.1186/1471-2369-12-57 Text en Copyright ©2011 Bataille et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bataille, Stanislas
Berland, Yvon
Fontes, Michel
Burtey, Stéphane
High Resolution Melt analysis for mutation screening in PKD1 and PKD2
title High Resolution Melt analysis for mutation screening in PKD1 and PKD2
title_full High Resolution Melt analysis for mutation screening in PKD1 and PKD2
title_fullStr High Resolution Melt analysis for mutation screening in PKD1 and PKD2
title_full_unstemmed High Resolution Melt analysis for mutation screening in PKD1 and PKD2
title_short High Resolution Melt analysis for mutation screening in PKD1 and PKD2
title_sort high resolution melt analysis for mutation screening in pkd1 and pkd2
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206831/
https://www.ncbi.nlm.nih.gov/pubmed/22008521
http://dx.doi.org/10.1186/1471-2369-12-57
work_keys_str_mv AT bataillestanislas highresolutionmeltanalysisformutationscreeninginpkd1andpkd2
AT berlandyvon highresolutionmeltanalysisformutationscreeninginpkd1andpkd2
AT fontesmichel highresolutionmeltanalysisformutationscreeninginpkd1andpkd2
AT burteystephane highresolutionmeltanalysisformutationscreeninginpkd1andpkd2